OCT 16, 2020 7:30 AM PDT

FDA Warns Against NSAIDs After Week 20 of Pregnancy

WRITTEN BY: Annie Lennon

The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 weeks into pregnancy. They say that usage of the drugs may cause a rare but serious kidney problem to the unborn child. While a well-known risk among certain medical specialties, the announcement comes as an effort to communicate more widely to other specialties and pregnant women. 

After around 20 weeks of gestation, unborn babies' kidneys produce most of the amniotic fluid they need- the protective cushion that helps their lungs, digestive system, and muscles develop. Kidney problems caused by the usage of NSAIDs can lead to lower levels of this fluid being produced, which can then lead to further health complications. 

The recommendations are the result of a review of medical literature, including case reports, randomized control studies, and observational studies. While most of the publications suggest that the condition, known as oligohydramnios, tends to occur in the third trimester, some reported an earlier onset from around 20 weeks of gestation. 

The review also stated that, in most cases, oligohydramnios was reversible within 72 hours to 6 days of discontinuing usage of the NSAID.

"It is important that women understand the benefits and risks of the medications they may take over the course of their pregnancy," says Patrizia Cavazzoni, MD, acting director of FDA's Center for Drug Evaluation and Research. "To this end, the agency is using its regulatory authority to inform women and their healthcare providers about the risks if NSAIDs are used after around 20 weeks of pregnancy and beyond."

The announcement comes after previous warnings against using NSAIDs, including ibuprofen and celecoxib, after week 30 of pregnancy due to heart-related risks. As such, manufacturers of NSAIDs will now be required to update their labeling. 

The FDA mentioned, however, that a low-dose (81mg) aspirin is excluded from the precaution. They also mentioned that if a healthcare provider believes that NSAIDs are necessary for women between week 20 and 30 of pregnancy, their usage should be limited to the lowest effective dose for the shortest duration possible. 

 

Sources: MedscapeFDA

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 21, 2021
Cannabis Sciences
Cannabis Capsule Combo Could Treat Alzheimer's
JUN 21, 2021
Cannabis Capsule Combo Could Treat Alzheimer's
Researchers led by Curtin University in Australia have developed tiny cannabidiol (CBD) capsules that could one day be u ...
JUL 11, 2021
Drug Discovery & Development
Antibiotic Resistance May Be Passed Between Dogs and Owners
JUL 11, 2021
Antibiotic Resistance May Be Passed Between Dogs and Owners
Household pets may act as a reservoir for mcr-1, a gene that is resistant to a last-resort antibiotic, colistin. The fin ...
JUL 15, 2021
Drug Discovery & Development
The genomics of high blood pressure - a road to the future of treatment
JUL 15, 2021
The genomics of high blood pressure - a road to the future of treatment
The human heart begins to beat in utero in the early weeks of development and continues throughout life. In an average l ...
AUG 01, 2021
Drug Discovery & Development
Berry Compound Reverses Parkinson's in Mice
AUG 01, 2021
Berry Compound Reverses Parkinson's in Mice
A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-a ...
AUG 17, 2021
Drug Discovery & Development
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
AUG 17, 2021
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
     Being tired throughout the day is a common feeling for most individuals. In fact, 1 out of every 5 A ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
Loading Comments...